Rinnerthaler, Gabriel
Singer, Christian
Petru, Edgar
Egle, Daniel
Petzer, Andreas
Pluschnig, Ursula
Gampenrieder, Simon Peter
Pfeiler, Georg
Gnant, Michael
Grünberger, Birgit
Krippl, Peter
Strasser-Weippl, Kathrin
Suppan, Christoph
Brunner, Christine
Pusch, Renate
Sandholzer, Margit
Balic, Marija http://orcid.org/0000-0001-9482-9191
Bartsch, Rupert
Funding for this research was provided by:
Daiichi-Sankyo Europe
Medical University of Graz
Article History
Received: 12 July 2022
Accepted: 10 August 2022
First Online: 23 September 2022
Conflict of interest
: G. Rinnerthaler: Consulting or advisory role: Piere Fabre, Celgene, Roche, Novartis, Pfizer, Eli Lilly, Daiichi-Sankyo, MSD. Speakers’ bureau: Amgen, AstraZeneca, Novartis, Bristol-Myers Squibb, Roche, Pfizer, Eli Lilly. Research funding: Roche. Travel, accommodations, expenses: Roche, Novartis, Amgen, Pfizer, Bristol-Myers Squibb. C. Singer: Advisory role: AstraZeneca, Daiichi-Sankyo, Eli-Lilly, Novartis, Pfizer, Roche. Lecture honoraria: AstraZeneca, Roche, Amgen, Eli-Lilly, Novartis, Pfizer. Research support: Daiichi, Amgen, Novartis, Roche. E. Petru: Honoraria for lectures: AGEA, Amgen, AstraZeneca, Angelini, Eisai, Eli Lilly, GlaxoSmithKline, MSD, Novartis, Pharma Mar, Pfizer, Roche, GILEAD, Seagen. Honoraria for advisory boards: Amgen, AstraZeneca, Angelini, Eisai, Eli Lilly, GlaxoSmithKline, MSD, Novartis, Pharma Mar, Pfizer, Roche, Clovis, Daiichi-Sankyo, Seagen, GILEAD. Honoraria (Institution): Amgen, AstraZeneca, Angelini, Eli Lilly, GlaxoSmithKline, Novartis, Pharma Mar, Pfizer, Roche, TESARO. Travel expenses: AGEA, Amgen, AstraZeneca, GlaxoSmithKline, Pharma Mar, Pfizer, Roche. D. Egle: Honoraria and Travel Grants: AstraZeneca, Amgen, Daiichi-Sankyo, Eli Lilly, MSD, Novartis, Pfizer, Roche, Seagen. A. Petzer: Honoraria, Advisory Role and/or Travel Support: Roche, Novartis, AstraZeneca, BMS-Celgene, Daiichi-Sankyo, Eisai, Eli-Lilly, Pfizer, Amgen, Seagen, Sanofi. U. Pluschnig: Advisory role: Roche, Eli-Lilly, Daiichi-Sankyo, AstraZeneca. Speaking: Roche. S.P. Gampenrieder: Speakers’ honoraria: Novartis, Roche, BMS, AstraZeneca, MSD, Seagen, Lilly. Advisory boards: Roche, Novartis, Pfizer, Lilly, AstraZeneca, MSD, BMS, Astellas, Daiichi-Sankyo, Sanofi, Seagen. Travel grants: Roche, Amgen, Shire, Novartis, Pfizer, Bayer, Celgene, Daiichi-Sankyo. Research funding: Roche. G. Pfeiler: Honoraria and grants: Daiichi-Sankyo, Amgen, Pfizer, AstraZeneca, MSD, Novartis, Roche, UCB, Pierre Fabre, Seagen, Eli-Lilly, Gilead. M. Gnant: Personal fees/travel support: Amgen, Daiichi-Sankyo, AstraZeneca, EliLilly, LifeBrain, Nanostring, Novartis, Pierre Fabre, MSD. Other: an immediate family member is employed by Sandoz. B. Grünberger: Speaker’s honoraria: MSD, BMS, Eli Lilly, Servier, Merck, Roche, Seagen, Gilead, AstraZeneca, Sanofi. Advisory boards: MSD, BMS, Merck, Roche, EliLilly, Seagen. Travel grants: MSD, BMS, Roche, Merck, Servier. P. Krippl: Honoraria: MSD, BMS, Eli Lilly, Servier, Merck, Roche, Gilead, AstraZeneca, Sanofi, Novartis, Pfizer, Celgene, Amgen, Pierre Fabre, Shire, Daiichi-Sankyo, Astellas. K. Strasser-Weippl: Travel support: Roche, Pfizer, MSD. Advisory Boards: Roche, Pfizer, Novartis, Lilly, Daiichi, Myriad, Seagen, MSD, Astra Zeneca. C. Suppan: Consulting or advisory role: Novartis, Pfizer, Eli Lilly, Daiichi-Sankyo. Speakers’ bureau: AstraZeneca, Novartis, Roche, Pfizer, Eli Lilly, Gilead. Travel, accommodations, expenses: Roche, Novartis, Pfizer. C. Brunner: Honoraria: AstraZeneca, Daiichi-Sankyo, Novartis, Pfizer, Roche, Seagen. R. Pusch: Honoraria: Novartis, Roche, Pfizer, Daiichi-Sankyo. Advisory Boards: Roche, Myriad, Amgen, Astra Zeneca, Lilly, Pfizer, Novartis. Travel support: Roche, Pfizer. M. Sandholzer: Advisory boards: Myriad, Novartis, AstraZeneca, Amgen, Roche, Pfizer, Pierre Fabre, Eli Lilly. Honoraria and travel grants: Novartis, Amgen, Servier, Roche, Eli Lilly, Pfizer, Merck. M. Balic: Research funding: AstraZeneca, Eli Lilly, Novartis, Pfizer, Samsung, Seagen. Advisory role: Amgen, AstraZeneca, Celgene, Daiichi-Sankyo, Eli Lilly, Gilead, MSD, Novartis, Pierre Fabre, Pfizer, Roche, Samsung, Seagen. Speaker’s bureau: Amgen, AstraZeneca, Celgene, Daiichi-Sankyo, Eli Lilly, Gilead, Novartis, Pierre Fabre, Pfizer, Roche, Seagen. R. Bartsch: Advisory Role: AstraZeneca, Daiichi, Eisai, Eli-Lilly, Gilead, MSD, Novartis, Pfizer, Pierre Fabre, Puma, Roche, Seagen. Lecture honoraria: AstraZeneca, Daiichi, Eli-Lilly, Gilead, Novartis, Pfizer, Pierre Fabre, Roche, Seagen. Research Support: Daiichi, MSD, Novartis, Roche.